News | Radiation Dose Management | May 02, 2016

SCAI Eye Exams for Interventional Cardiologists Helps Track Radiation Exposure

Effort to track radiation exposure impact on cath lab staff begins at SCAI 2016

radiation dose in the cath lab

May 2, 2016 — Starting at the Society for Cardiovascular Angiography and Interventions (SCAI) 2016 annual meeting May 4-6, SCAI will begin efforts to collect real data on the impact of radiation-induced cataracts amongst the cardiovascular cath lab team.

Through the IC-CATARACT initiative led by Manos Brilakis, M.D., Ph.D., FSCAI, and his team of researchers from VA North Texas Healthcare System and UT Southwestern Medical Center, will offer free eye exams at the SCAI meeting in the IC-CATARACT suite in the exhibit hall. 

The full extent of these radiation risks is not yet known and SCAI is starting this effort to focus on the well-being and health of its members. The society will be focusing on workplace issues in the coming year. 

Support of this initiative provided by Dallas VA Research Corp.

On the morning of Thursday, May 5, the SCAI Quality Track will focus on safety in the cath lab as well with two morning sessions, “Interventional Medicine: Occupational Hazards? You Bet Your Life,” and Minimizing Occupational Hazards of Interventional Medicine: Tips and Tricks.”

For more information: www.scai.org/SCAI2016/Detail.aspx?cid=6360c846-1b75-4a48-b28e-d98710b122c8

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init